In tablet manufacturing, Tongguan Powder is screened through a 0.600 mm oscillating sieve prior to dispensing. The retained fraction above 0.600 mm is milled in a Fitz mill fitted with a 0.020 in screen at 2,500 rpm. Bulk density is measured per USP <616> with a 100 mL graduated cylinder. If bulk density falls below 0.40 g/cm³, direct compression is rejected in favor of wet granulation. A direct compression batch uses 12.5% w/w Tongguan Powder, 62.0% w/w microcrystalline cellulose PH-102, 20.5% w/w lactose monohydrate, 4.0% w/w crospovidone, and 1.0% w/w magnesium stearate. The dry blend is mixed in a 600 L twin-shell V-blender at 12 rpm for 15 minutes. Magnesium stearate is added last and mixed for 3 minutes. Blend uniformity is tested by sampling 10 positions using a stainless-steel thief. Acceptance is 90.0%–110.0% of label claim with RSD ≤ 5.0% according to the FDA guidance for powder blend uniformity. The final blend is compressed on a 16-station rotary tablet press with 8.0 mm round tooling. Turret speed is set at 45 rpm giving a dwell time near 0.18 seconds. Compression force is maintained between 8 kN and 14 kN. In-process weight variation is checked every 10 minutes and must remain within ±5.0% of target weight. If weight variation exceeds 5.0%, the press is stopped and die-fill cam position inspected. Hardness is tested every 15 minutes and must remain 60–90 N. Friability is tested per USP <1216> and must not exceed 0.8%. Disintegration time in 37°C purified water is tested per USP <701> and is expected to be less than 15 minutes. Terminal products are veterinary oral tablets for companion-animal or calf dosing.

What Controls Sterile Filtration Pressure Drop During Injection Finishing?

Tongguan Powder is dispersed in Water for Injection cooled to 20–25°C under continuous agitation. The solution is pH-adjusted to 6.5–7.5 with 0.1 N hydrochloric acid or sodium hydroxide. For a 50 mg/mL fill concentration, osmolality is corrected with 0.65–0.75% w/v sodium chloride. The batch is circulated through a 0.45 µm polyvinylidene difluoride clarifying filter for 20 minutes. The solution is then passed through a 0.22 µm polyethersulfone sterilizing filter. Pressure differential across the sterilizing membrane should remain below 12 psi at 20°C. A pressure rise above 12 psi triggers filter replacement and retest for bacterial endotoxins per USP <85>. Filter integrity is verified before and after use by bubble point testing per ASTM F838-20; accepted bubble point is ≥ 3.2 bar. The solution is filled into 100 mL Type I borosilicate vials under Grade A laminar airflow with Grade B background. Stoppers are pre-dried to moisture below 0.4%. Terminal sterilization at 121°C for 15 minutes is selected only where stability data confirm no assay loss greater than 5.0%. Sterility testing of finished vials follows USP <71> with a minimum incubation of 14 days. Bacterial endotoxin limit is set below 0.5 EU/mg. Terminal products are sterile injectable solutions for cattle, swine, or companion-animal administration.

Capsule filling with Tongguan Powder is operated on a tamping-pin capsule machine. The API is premixed with 0.5% w/w colloidal silicon dioxide and 2.0% w/w sodium stearyl fumarate before loading into the hopper. Lactose monohydrate and pregelatinized starch are used as fillers at 15.0% w/w and 10.0% w/w respectively. The powder bed height is maintained at 1.2–1.5 times the dosator diameter. Gelatin capsule shells size 0 or size 1 are conditioned to a shell moisture of 13.0–15.5%. Fill weight variation is checked every 30 minutes and must comply with USP <905> acceptance value ≤ 15.0. Empty capsules are rejected if visual inspection identifies cracks, dents, or separation. Filled capsules are dedusted with a rotating brush assembly and metal detected at 1.5 mm ferrous sensitivity. In-process checks include fill weight, shell moisture, and closure length. Terminal products are oral capsules for equine, bovine, or companion-animal delivery where individualized dosing is required.

When Double-Cone Blending Fails to Meet Blend Uniformity Acceptance Criteria

Powder sachet lines for Tongguan Powder use a 1000 L V-blender loaded to 0.7 fill ratio. The API is pre-screened through a 0.600 mm sieve. The primary diluent is lactose monohydrate. A representative formulation uses 20.0% w/w Tongguan Powder, 79.0% w/w lactose monohydrate, 0.5% w/w colloidal silicon dioxide, and 0.5% w/w sodium lauryl sulfate. Geometric dilution is performed in four steps to avoid segregation. Blending proceeds at 12 rpm for 15 minutes. Samples are taken from 10 sampling points with a unit-dose thief. Blend uniformity acceptance is 90.0%–110.0% label claim with RSD ≤ 5.0%. If RSD exceeds 5.0%, the blender is operated for an additional 5 minutes but not beyond 25 minutes total. Prolonged blending above 25 minutes can cause fines migration and demixing. Powder fill into aluminum-foil sachets is performed on a vertical form-fill-seal machine. Seal integrity is verified per ASTM F88/F88M-23 with minimum seal strength 2.0 lb/in. Terminal products are water-soluble oral powders for swine administered through drinking water or top-dressing feed.

Fluid bed granulation converts Tongguan Powder into free-flowing granules for oral suspension or direct administration. A top-spray 120 L fluid bed is charged with 10.0% w/w Tongguan Powder, 75.0% w/w lactose monohydrate, and 10.0% w/w pregelatinized starch. The binder solution is 5.0% w/w povidone K-30 in purified water. Spray rate is maintained at 180–250 g/min. Inlet air temperature is 60–70°C. Product temperature is held at 32–38°C. Atomizing air pressure is 2.0–2.5 bar. Inlet air humidity is controlled with a dehumidifier to a dew point below 10°C because higher humidity causes bed channeling and uneven granule growth. Drying continues until loss on drying is 1.5–2.5% as measured by USP <731>. The dried granules are milled through a 1.5 mm conical screen. Flow rate through a 10 mm orifice is 4–10 g/s as measured by USP <1174>. Bulk density is targeted at 0.55–0.70 g/cm³. Terminal products are granules for reconstitution or direct oral administration in poultry and swine.

Premix Carrier Selection and Carry-Over Limits

Tongguan Powder is diluted into a Type A medicated premix at 50–200 g/kg active substance. Ground corn cob 14/40 mesh is selected as the carrier. Mineral oil is sprayed at 1.0–2.0% w/w to reduce dust. Mixing is performed in a horizontal paddle mixer for 10 minutes. Mixer coefficient of variation is tested by sampling 10 cross-sectional points and must remain ≤ 10.0%. After discharge, the mixer must be flushed with 25 kg ground corn or soybean meal. Carry-over into a subsequent non-medicated batch is controlled below 1.0% of the preceding batch size per FDA 21 CFR 225.58. Terminal products are medicated feed premixes for livestock feed mills. Published data for Tongguan Powder-specific carry-over in this exact mixer configuration is limited; therefore transfer limits are set at the default 1.0% value and verified by tracer studies.

Assessing Drinking Water Solution Stability over 48 Hours

Drinking water formulations using Tongguan Powder begin with a stock solution at 10.0% w/v in purified water. The stock is diluted to 0.01–0.10% w/v at the medicator or proportioner. The diluted solution is buffered to pH 5.5–6.5 using a citric acid-sodium citrate system. Turbidity is monitored with a portable nephelometer and must not exceed NTU 10. The solution is stored in black HDPE IBC totes to limit photodegradation. Chemical stability is sampled at 0, 24, 48 hours and must show assay remaining within 90.0–110.0% of the initial concentration per VICH GL3. If pH drifts above 6.5, precipitation may occur and the batch is quarantined. Water hardness above 150 ppm calcium carbonate may reduce solubility and requires pre-treatment with a water softener or chelating system. The proportioner is flushed with water after each use. Terminal products are liquid concentrates for poultry and swine drinking water medication.